Search
Interleukin-21 receptor
go.drugbank.com/bio_entities/BE0010657TargetHumansThis is a receptor for interleukin-21
Polypeptides: Interleukin-21 receptorSynonyms: IL-21 receptor, Novel interleukin receptorNeuromedin-B receptor
go.drugbank.com/bio_entities/BE0013104TargetHumansReceptor for neuromedin-B (PubMed:1655761). … Plays a role in CSF1-induced proliferation of osteoclast precursors by contributing to the positive regulation of the expression of the CSF1 receptor CSF1R (By similarity)
Polypeptides: Neuromedin-B receptorSynonyms: Neuromedin-B-preferring bombesin receptorInterleukin-23 receptor
go.drugbank.com/bio_entities/BE0015564TargetHumansAssociates with IL12RB1 to form the interleukin-23 receptor.
Polypeptides: Interleukin-23 receptorSynonyms: IL-23 receptorDiscoidin domain receptor
go.drugbank.com/bio_entities/BE0027487TargetHumansRegulates osteoblast differentiation and chondrocyte maturation via a signaling pathway that involves MAP kinases and leads to the activation of the transcription factor RUNX2. … It functions as a cell surface receptor for fibrillar collagen and regulates cell differentiation, remodeling of the extracellular matrix, cell migration and cell proliferation.
Polypeptides: Discoidin domain-containing receptor 2, Epithelial discoidin domain-containing receptor 1Synonyms: Discoidin domain receptor 2, Discoidin receptor tyrosine kinaseInterleukin-2 receptor
go.drugbank.com/bio_entities/BE0027978TargetHumansReceptor for interleukin-2. This beta subunit is involved in receptor mediated endocytosis and transduces the mitogenic signals of IL2. … Receptor for interleukin-2. The receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity.
Polypeptides: Cytokine receptor common subunit gamma, Interleukin-2 receptor subunit alphaSynonyms: IL-2 receptor subunit gamma, IL-2 receptor subunit alphaPretomanid
go.drugbank.com/drugs/DB05154ApprovedInvestigationalResearch in recent years has been geared toward the development of novel therapies that target persistent forms of this disease, which have shown resistance to standard therapy regimens.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesFondaparinux
go.drugbank.com/drugs/DB00569ApprovedInvestigationalknee surgery); to prevent VTE in patients undergoing abdominal surgery who are are at high risk of thromboembolic complications; in the treatment of deep vein thrombosis (DVT) and pumonary embolism (PE
Cannabinoid receptor 1
go.drugbank.com/bio_entities/BE0000061TargetHumansG protein-coupled receptor for endogenous cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2-arachidonoylglycerol (2-AG), as well as phytocannabinoids, such
Polypeptides: Cannabinoid receptor 1Function: cannabinoid receptor activityCannabinoid receptor 2
go.drugbank.com/bio_entities/BE0000095TargetHumansHeterotrimeric G protein-coupled receptor for endocannabinoid 2-arachidonoylglycerol mediating inhibition of adenylate cyclase.
Polypeptides: Cannabinoid receptor 2Function: cannabinoid receptor activitySubstance-P receptor
go.drugbank.com/bio_entities/BE0000384TargetHumansSubstance P binding to its receptor triggers G protein-coupled receptor signaling via activation of phosphatidylinositol hydrolysis by phospholipase C. … Substance P binding also triggers signaling via activation of adenylate cyclase activity which results in increased intracellular levels of cyclic AMP (cAMP) (By similarity)
Polypeptides: Substance-P receptorSynonyms: NK-1 receptor, Tachykinin receptor 1